Accelerate Diagnostics Revenue and Competitors
Estimated Revenue & Valuation
- Accelerate Diagnostics's estimated annual revenue is currently $39.2M per year.
- Accelerate Diagnostics's estimated revenue per employee is $251,000
Employee Data
- Accelerate Diagnostics has 156 Employees.
- Accelerate Diagnostics grew their employee count by -14% last year.
Accelerate Diagnostics's People
Name | Title | Email/Phone |
---|---|---|
1 | Head Global Marketing & Strategy | Reveal Email/Phone |
2 | Head, Software Engineering | Reveal Email/Phone |
3 | SVP, Head Operations | Reveal Email/Phone |
4 | Head Human Resources | Reveal Email/Phone |
5 | Head, Scientific Marketing | Reveal Email/Phone |
6 | Head Operations | Reveal Email/Phone |
7 | SVP, Head Research and Development | Reveal Email/Phone |
8 | Head OF Field Service Engineers EMEA | Reveal Email/Phone |
9 | Regional Business Director | Reveal Email/Phone |
10 | Regional Commercial Development Director | Reveal Email/Phone |
Accelerate Diagnostics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $13.8M | 55 | 49% | N/A | N/A |
#2 | $9.8M | 39 | 0% | N/A | N/A |
#3 | $0.5M | 4 | 0% | N/A | N/A |
#4 | $20.3M | 81 | 65% | N/A | N/A |
#5 | $10.8M | 43 | 0% | N/A | N/A |
#6 | $28.1M | 112 | -3% | $83.2M | N/A |
#7 | $6.5M | 26 | 0% | N/A | N/A |
#8 | $8M | 19 | 0% | N/A | N/A |
#9 | $11M | 57 | 6% | N/A | N/A |
#10 | $12M | 48 | 7% | N/A | N/A |
What Is Accelerate Diagnostics?
Accelerate Diagnostics, Inc. (Nasdaq:AXDX), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. The company's revolutionary ID/AST platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. In addition to the ID/AST development pipeline, the company also owns and licenses its proprietary OptiChem surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.
keywords:N/AN/A
Total Funding
156
Number of Employees
$39.2M
Revenue (est)
-14%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Accelerate Diagnostics News
Accelerate Diagnostics Inc (AXDX) stock is down -86.90% over the last 12 months, and the average rating from Wall Street analysts is a Hold.
In-vitro diagnostics firm Accelerate Diagnostics has launched the Accelerate Arc system for quick and accurate microbial identification of...
Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $17.5M | 159 | 31% | N/A |
#2 | $40.7M | 162 | 9% | N/A |
#3 | $15M | 164 | 8% | N/A |
#4 | $27.2M | 165 | 15% | N/A |
#5 | $7.5M | 166 | 9% | N/A |